1203O FOLFOX plus nivolumab and ipilimumab versus FOLFOX induction followed by nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Results from the randomized phase II Moonlight trial of the AIO
| Autor: | S. Lorenzen, P.C. Thuss-Patience, G. Folprecht, J. Riera Knorrenschild, V. Heinemann, E. Goekkurt, T.N. Dechow, T.J. Ettrich, K.B. Luley, J-C. Moulin, U. Lindig, S. Angermeier, O. Waidmann, D. Pink, C. Bolling, S. Junge, C. Pauligk, T. Gaiser, T.O. Götze, S-E. Al-Batran |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Annals of Oncology. 33:S1099 |
| ISSN: | 0923-7534 |
| DOI: | 10.1016/j.annonc.2022.07.1321 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|